{"entity":{"id":"nct06609551","kind":"trial","name":"ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study","aka":["ZJCH-CRCC-1"],"tldr":"A phase 3 trial in colorectal cancer, run by Zhejiang Cancer Hospital, now recruiting.","summary":"ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study is a phase 3, randomised interventional study registered as NCT06609551 by Zhejiang Cancer Hospital, with a registry enrolment figure of 312 participants, started 2024-07-03 and due to reach its primary completion in 2029-12-31. Interventions recorded: 6-month adjuvant chemotherapy with 5-FU monotherapy; XELOX intensive treatment group. Conditions listed: Colon Cancer; Colon Cancer (Stage II &Amp;Amp;Amp; III). Primary outcome: 2-year DFS (Disease-Free Survival). Colorectal eligibility wording from the registry: \"Patients with histopathologically confirmed stage II high-risk or stage III colon cancer;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06609551","url":"https://clinicaltrials.gov/study/NCT06609551"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["colon-cancer"],"sections":[],"technologies":["mrd-testing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06609551","phase":"3","setting":"ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study","sponsor":"Zhejiang Cancer Hospital","enrolled":312,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06609551/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"}],"technology":[{"id":"mrd-testing","kind":"technology","name":"MRD / molecular residual disease testing","route":"/technologies/mrd-testing/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}